LIN Total Non-Current Liabilities

Linde plc · Total Non-Current Liabilities

LIN logo

LIN Total Non-Current Liabilities

Latest reported$31.59B
LIN Quarterly Total Non-Current Liabilities ($557.00M → $31.59B)
High-resolution chart · PNG

LIN total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Linde plc Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
31,592,000,000
30,832,000,000
31,878,000,000
29,715,000,000
31,378,000,000
28,756,000,000
26,115,000,000
27,894,000,000
27,160,000,000
25,729,000,000
23,999,000,000
23,427,000,000
22,918,000,000
21,187,000,000
21,792,000,000
20,323,000,000
21,550,000,000
23,871,000,000
22,521,000,000
23,696,000,000
22,441,000,000
22,333,000,000
24,907,000,000
23,825,000,000
22,824,000,000
21,636,000,000
22,817,000,000
22,203,000,000
23,774,000,000
23,854,000,000
23,334,000,000
9,369,000,000
10,015,000,000
10,161,000,000
10,607,000,000
10,711,000,000
10,652,000,000
11,441,000,000
11,402,000,000
11,803,000,000
11,794,000,000
11,802,000,000
11,520,000,000
11,521,000,000
11,302,000,000
11,225,000,000
11,126,000,000
10,294,000,000
10,879,000,000
10,911,000,000
10,281,000,000
10,268,000,000
10,237,000,000
10,119,000,000
8,938,000,000
8,502,000,000
8,066,000,000
8,566,000,000
8,024,000,000
7,612,000,000
7,644,000,000
7,376,000,000
7,019,000,000
6,863,000,000
6,766,000,000
6,808,000,000
6,856,000,000
6,729,000,000
6,164,000,000
5,817,000,000
5,764,000,000
5,587,000,000
5,722,000,000
5,572,000,000
5,269,000,000
5,109,000,000
5,258,000,000
5,195,000,000
4,568,000,000
4,329,000,000
4,034,000,000
4,210,000,000
4,386,000,000
4,243,000,000
4,165,000,000
4,133,000,000
4,170,000,000
3,479,000,000
4,062,000,000
3,927,000,000
3,905,000,000
3,953,000,000
3,936,000,000
3,835,000,000
3,797,000,000
3,794,000,000
3,917,000,000
3,901,000,000
3,903,000,000
4,052,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.